Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$902K Buy
32,683
+15,094
+86% +$333K ﹤0.01% 1415
2026
Q1
$257K Buy
17,589
+3,938
+29% +$57.8K ﹤0.01% 1802
2025
Q4
$173K Buy
+13,651
New +$201K ﹤0.01% 1775
2025
Q2
Sell
-137
Closed -$2.16K 2078
2025
Q1
$2.16K Buy
137
+40
+41% +$875 ﹤0.01% 1958
2024
Q4
$2.44K Buy
+97
New +$2.71K ﹤0.01% 1981
2023
Q2
Sell
-2,045
Closed -$37.6K 2119
2023
Q1
$37.6K Sell
2,045
-12,370
-86% -$237K ﹤0.01% 1914
2022
Q4
$238K Buy
+14,415
New +$256K ﹤0.01% 1493

Other funds holding RXO

Amundi's RXO Position: Q2 2026 in Review

Amundi increased its RXO (RXO) stake by 86% in Q2 2026, buying an estimated $333K and bringing the position to 32,683 shares worth $902K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Amundi first reported a position in RXO in Q4 2022 and has held it in 7 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Amundi held 32,683 shares of RXO worth $902K as of Q2 2026.
  • Amundi bought 15,094 RXO shares in Q2 2026, an estimated $333K.
  • RXO made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1415 holding.
  • Amundi first reported a position in RXO in Q4 2022 and has held it in 7 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.